Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PEOPLE - Bristol-Myers Squibb (US) makes appointment:

This article was originally published in Clinica

Executive Summary

Bristol-Myers Squibb (Princeton, New Jersey) has appointed three key senior directors for the department of corporate development. Jack Geltosky, who most recently served as president and CEO of Message Pharmaceuticals, has been appointed as vice-president of external science, technology and licensing. Graham Brazier, who most recently served as senior vice-president of corporate development at 3-Dimensional Pharmaceuticals, has been appointed as vice-president of business development. James Foley, who has been appointed as vice-president of business development in Japan and Asia, most recently served in the same capacity at GlaxoSmithKline.

Topics

UsernamePublicRestriction

Register

MT066144

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel